Metabolomics research at the University of Birmingham began in 2003 and now encompasses multiple research teams in the Schools of Biosciences, Computer Science, Mathematics, Cancer Sciences, Immunity & Infection, and Clinical & Experimental Medicine.
Our research focuses primarily in clinical metabolomics and environmental metabolomics, and is strongly underpinned by the development of novel bioanalytical and computational methodologies. The bioanalytical facilities and expertise in both NMR spectroscopy and mass spectrometry based metabolomics at Birmingham are world class, including the Henry Wellcome Building for Biomolecular NMR Spectroscopy and the national NERC Biomolecular Analysis Facility for metabolomics. In 2010 the University invested considerable funding into the Systems Science for Health initiative, further strengthening the integration of metabolomics, computational biology and translational medicine. The metabolomics research is also supported by the BBSRC, NERC, EPSRC, MRC, EU and the Wellcome Trust.